Smartphone Addiction in Relation to Trunk Position Sense, Fatigue and Insomnia in Adolescences
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Mohamed M ElMeligie, Ph.D
- Phone Number: +2 01064442032
- Email: mohamed.magdy.pt@o6u.edu.eg
Study Locations
-
-
Giza
-
Al Ḩayy Ath Thāmin, Giza, Egypt, 12533
- Recruiting
- October 6 university hospital
-
Contact:
- Mohamed M ElMeligie, Ph.D
- Phone Number: +2 01064442032
- Email: mohamed.magdy.pt@o6u.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adolescents with age between 17 and 18 years old.
- BMI between 16.4 and 24.8 kg/m2
- Smartphone addiction scale (short version) higher than 33
- Smartphone users of 4-5 inches screen size smartphones, weighing 140-160 grams and dimensions less than 159*79*9 mm.
Exclusion Criteria:
- Visual or hearing defects.
- Congenital abnormalities.
- Neurological abnormalities
- Musculoskeletal abnormalities
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Smartphone addiction group
|
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trunk position sense
Time Frame: Single measurement (instant measure)
|
Digital goniometer will be used to determine trunk position sense.
Procedure will be performed with open-closed eye positions with a trunk flexion and trunk lateral bending right/left without any verbal feedback from the examiner.
It will be measured in terms of repositioning error angle (the difference between reached and targeted angles).
|
Single measurement (instant measure)
|
|
Insomnia severity index
Time Frame: Single measurement (instant measure)
|
Insomnia severity will be assessed by insomnia severity index.
It contains 7 items and each participant will read each statement and check a number from 0 to 4. respondents use five point LIKERT scale to rate each item (example: 0= no problem, 4= very severe problems).
|
Single measurement (instant measure)
|
|
Fatigue severity scale
Time Frame: Single measurement (instant measure)
|
Arabic version of fatigue severity scale will be used to determine fatigue level.
It contains 9 items as each participant will be asked to read each statement and circle a number from 1(completely disagree) to 7 "completely agree"/
|
Single measurement (instant measure)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Elham E Salem, Professor of Physical Therapy, Cairo University
- Study Director: Walaa A Abdelnabie, Professor of Physical Therapy, Cairo University
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- smartphone003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.